Medicinal chemistry of atp synthase: A potential drug target of dietary polyphenols and amphibian antimicrobial peptides

Current Medicinal Chemistry

Volumn 17, Issue 25, 2010, Pages 2822-2836

  Ahmad, Zulfiqar ^a   Laughlin, Thomas F ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Amphibian antimicrobial peptides; Atpase; Dietary polyphenols; E. coli atp synthase; Enzyme inhibitors; F1foatp synthase

Indexed keywords

AMANTADINE; AMPHIBIAN ANTIMICROBIAL PEPTIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; APIGENIN; BAICALEIN; CATECHOL; CHRYSIN; DAIDZEIN; DIOSMIN; DITHRANOL; EPICATECHIN; GENISTEIN; HESPERIDIN; HYDROQUINONE; KAEMPFEROL; LUTEOLIN; MORIN; PEPTIDE; PICEATANNOL; POLYPHENOL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; QUERCETIN; QUERCITRIN; RESORCINOL; RESVERATROL; RIMANTADINE; SILIBININ; SILYMARIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CELL GROWTH; DIETARY INTAKE; DRUG TARGETING; ESCHERICHIA COLI; HUMAN; STRUCTURE ACTIVITY RELATION;

AMPHIBIANS; ANIMALS; ANTI-INFECTIVE AGENTS; BINDING SITES; ESCHERICHIA COLI; FLAVONOIDS; HUMANS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; PEPTIDES; PHENOLS; PROTEIN BINDING; RATS;

EID: 77955596298     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791859270     Document Type: Article

References (196)

1. Senior, A.E.; Nadanaciva, S.; Weber, J. The molecular mechanism of ATP synthesis by F1F0-ATP synthase. Biochim. Biophys. Acta, 2002, 1553, 188-211.
2. Boyer, P.D. The ATP synthase-a splendid molecular machine. Annu. Rev. Biochem., 1997, 66, 717-749.
3. Van Walraven, H.S.; Strotmann, H.; Schwarz, O.; Rumberg, B. The H+/ATP coupling ratio of the ATP synthase from thiol-modulated chloroplasts and two cyanobacterial strains is four. FEBS Lett., 1996, 379, 309-313.
4. Yoshida, M.; Muneyuki, E.; Hisabori, T. ATP synthase-a marvellous rotary engine of the cell. Nat. Rev. Mol. Cell Biol., 2001, 2, 669-677.
5. Schemidt, R.A.; Qu, J.; Williams, J.R.; Brusilow, W.S. Effects of carbon source on expression of F0 genes and on the stoichiometry of the c subunit in the F1F0 ATPase of Escherichia coli. J. Bacteriol., 1998, 180, 3205-3208.
6. Senior, A.E. ATP synthesis by oxidative phosphorylation. Physiol. Rev., 1988, 68, 177-231.
7. Karrasch, S.; Walker, J.E. Novel features in the structure of bovine ATP synthase. J. Mol. Biol., 1999, 290, 379-384.
8. Devenish, R.J.; Prescott, M.; Roucou, X.; Nagley, P. Insights into ATP synthase assembly and function through the molecular genetic manipulation of subunits of the yeast mitochondrial enzyme complex. Biochim. Biophys. Acta, 2000, 1458, 428-442.
9. Diez, M.; Zimmermann, B.; Borsch, M.; Konig, M.; Schweinberger, E.; Steigmiller, S.; Reuter, R.; Felekyan, S.; Kudryavtsev, V.; Seidel, C.A.M.; Graber, P. Proton-powered subunit rotation in single membrane-bound F0F1-ATP synthase. Nat. Struct. Mol. Biol., 2004, 11, 135-141.
10. Itoh, H.; Takahashi, A.; Adachi, K.; Noji, H.; Yasuda, R.; Yoshida, M.; Kinosita, K. Mechanically driven ATP synthesis by F1-ATPase. Nature, 2004, 427, 465-468.
11. Weber, J. ATP synthase: subunit-subunit interactions in the stator stalk. Biochim. Biophys. Acta, 2006, 1757, 1162-1170.
12. Weber, J.; Senior, A.E. ATP synthase: what we know about ATP hydrolysis and what we do not know about ATP synthesis. Biochim. Biophys. Acta, 2000, 1458, 300-309.
13. Senior, A.E.; Nadanaciva, S.; Weber, J. Rate acceleration of ATP hydrolysis by F(1)F(o)-ATP synthase. J. Exp. Biol., 2000, 203, 35-40.
14. Frasch, W.D. The participation of metals in the mechanism of the F(1)-ATPase. Biochim. Biophys. Acta, 2000, 1458, 310-325.
15. Nakamoto, R.K.; Ketchum, C.J.; al-Shawi, M.K. Rotational coupling in the F0F1 ATP synthase. Annu. Rev. Biophys. Biomol. Struct., 1999, 28, 205-234.
16. Pedersen, P.L. Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease. J. Bioenerg. Biomembr., 2007, 39, 349-355.
17. Ahmad, Z.; Senior, A.E. Identification of phosphate binding residues of Escherichia coli ATP synthase. J. Bioenerg. Biomembr., 2005, 37, 437-440.
18. Senior, A.E. ATP synthase: motoring to the finish line. Cell, 2007, 130, 220-221.
19. Noji, H.; Yoshida, M. The rotary machine in the cell, ATP synthase. J. Biol. Chem., 2001, 276, 1665-1668.
20. Weber, J.; Senior, A.E. ATP synthesis driven by proton transport in F1F0-ATP synthase. FEBS Lett., 2003, 545, 61-70.
21. Khan, S. Rotary chemiosmotic machines. Biochim. Biophys. Acta, 1997, 1322, 86-105.
22. Ren, H.; Allison, W.S. On what makes the gamma subunit spin during ATP hydrolysis by F(1). Biochim. Biophys. Acta, 2000, 1458, 221-233.
23. Leslie, A.G.; Walker, J.E. Structural model of F1-ATPase and the implications for rotary catalysis. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2000, 355, 465-471.
24. Menz, R.I.; Walker, J.E.; Leslie, A.G. Structure of bovine mitochondrial F(1)-ATPase with nucleotide bound to all three catalytic sites: implications for the mechanism of rotary catalysis. Cell, 2001, 106, 331-341.
25. Boyer, P.D. A perspective of the binding change mechanism for ATP synthesis. FASEB J., 1989, 3, 2164-2178.
26. Boyer, P.D. Aresearch journey with ATP synthase. J. Biol. Chem., 2002, 277, 39045-39061.
27. Noji, H.; Yasuda, R.; Yoshida, M.; Kinosita, K. Jr. Direct observation of the rotation of F1-ATPase. Nature, 1997, 386, 299-302.
28. Kinosita, K. Jr.; Yasuda, R.; Noji, H.; Ishiwata, S.; Yoshida, M. F1-ATPase: a rotary motor made of a single molecule. Cell, 1998, 93, 21-24.
29. Nishizaka, T.; Oiwa, K.; Noji, H.; Kimura, S.; Muneyuki, E.; Yoshida, M.; Kinosita, K. Jr. Chemomechanical coupling in F1-ATPase revealed by simultaneous observation of nucleotide kinetics and rotation. Nat. Struct. Mol. Biol., 2004, 11, 142-148.
30. Senior, A.E.; Weber, J. Happy motoring with ATP synthase. Nat. Struct. Mol. Biol., 2004, 11, 110-112.
31. Yasuda, R.; Noji, H.; Kinosita, K. Jr.; Yoshida, M. F1-ATPase is a highly efficient molecular motor that rotates with discrete 120 degree steps. Cell, 1998, 93, 1117-1124.
32. Whitesides, G.M. The 'right' size in nanobiotechnology. Nat. Biotechnol., 2003, 21, 1161-1165.
33. Li, W.; Brudecki, L.E.; Senior, A.E.; Ahmad, Z. Role of {alpha}-subunit VISIT-DG sequence residues Ser-347 and Gly-351 in the catalytic sites of Escherichia coli ATP synthase. J. Biol. Chem., 2009, 284, 10747-10754.
34. Dadi, P.K.; Ahmad, M.; Ahmad, Z. Inhibition of ATPase activity of Escherichia coli ATP synthase by polyphenols. Int. J. Biol. Macromol., 2009, 45, 72-79.
35. Laughlin, T.F.; Ahmad, Z. Inhibition of Escherichia coli ATP synthase by amphibian antimicrobial peptides. Int. J. Biol. Macromol., 2010.
36. Weber, J.; Wilke-Mounts, S.; Lee, R.S.; Grell, E.; Senior, A.E. Specific placement of tryptophan in the catalytic sites of Escherichia coli F1-ATPase provides a direct probe of nucleotide binding: maximal ATP hydrolysis occurs with three sites occupied. J. Biol. Chem., 1993, 268, 20126-20133.
37. Lobau, S.; Weber, J.; Senior, A.E. Catalytic site nucleotide binding and hydrolysis in F1F0-ATP synthase. Biochemistry, 1998, 37, 10846-10853.
38. Weber, J.; Hammond, S.T.; Wilke-Mounts, S.; Senior, A.E. Mg2+coordination in catalytic sites of F1-ATPase. Biochemistry, 1998,37, 608-614.
39. Dou, C.; Fortes, P.A.; Allison, W.S. The alpha 3(beta Y341W)3 gamma subcomplex of the F1-ATPase from the thermophilic Bacillus PS3 fails to dissociate ADP when MgATP is hydrolyzed at a single catalytic site and attains maximal velocity when three catalytic sites are saturated with MgATP. Biochemistry, 1998, 37, 16757-16764.
40. al-Shawi, M.K.; Senior, A.E. Effects of dimethyl sulfoxide on catalysis in Escherichia coli F1-ATPase. Biochemistry, 1992, 31, 886-891.
41. Al-Shawi, M.K.; Ketchum, C.J.; Nakamoto, R.K. The Escherichia coli FOF1 gammaM23K uncoupling mutant has a higher K0.5 for Pi. Transition state analysis of this mutant and others reveals that synthesis and hydrolysis utilize the same kinetic pathway. Biochemistry, 1997, 36, 12961-12969.
42. Rastogi, V.K.; Girvin, M.E. Structural changes linked to proton translocation by subunit c of the ATP synthase. Nature, 1999, 402, 263-268.
43. Gibbons, C.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. The structure of the central stalk in bovine F(1)-ATPase at 2.4 A resolution. Nat. Struct. Biol., 2000, 7, 1055-1061.
44. Braig, K.; Menz, R.I.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. Structure of bovine mitochondrial F(1)-ATPase inhibited by Mg(2+) ADP and aluminium fluoride. Structure, 2000, 8, 567-573.
45. Weber, J.; Senior, A.E. Location and properties of pyrophosphatebinding sites in Escherichia coli F1-ATPase. J. Biol. Chem., 1995, 270, 12653-12658.
46. Perez, J.A.; Greenfield, A.J.; Sutton, R.; Ferguson, S.J. Characterisation of phosphate binding to mitochondrial and bacterial membrane-bound ATP synthase by studies of inhibition with 4-chloro-7-nitrobenzofurazan. FEBS Lett., 1986, 198, 113-118.
47. Orriss, G.L.; Leslie, A.G.; Braig, K.; Walker, J.E. Bovine F1-ATPase covalently inhibited with 4-chloro-7-nitrobenzofurazan: the structure provides further support for a rotary catalytic mechanism. Structure, 1998, 6, 831-837.
48. Ahmad, Z.; Senior, A.E. Mutagenesis of residue betaArg-246 in the phosphate-binding subdomain of catalytic sites of Escherichia coli F1-ATPase. J. Biol. Chem., 2004, 279, 31505-31513.
49. Ahmad, Z.; Senior, A.E. Role of betaAsn-243 in the phosphatebinding subdomain of catalytic sites of Escherichia coli F(1)-ATPase. J. Biol. Chem., 2004, 279, 46057-46064.
50. Ahmad, Z.; Senior, A.E. Involvement of ATP synthase residues alphaArg-376, betaArg-182, and betaLys-155 in Pi binding. FEBS Lett., 2005, 579, 523-528.
51. Ahmad, Z.; Senior, A.E. Modulation of charge in the phosphate binding site of Escherichia coli ATP synthase. J. Biol. Chem., 2005, 280, 27981-27989.
52. Ahmad, Z.; Senior, A.E. Inhibition of the ATPase activity of Escherichia coli ATP synthase by magnesium fluoride. FEBS Lett., 2006, 580, 517-520.
53. Hong, S.; Pedersen, P.L. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol. Mol. Biol. Rev., 2008, 72, 590-641.
54. de Vries, D.D.; van Engelen, B.G.; Gabreels, F.J.; Ruitenbeek, W.; van Oost, B.A. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann. Neurol., 1993, 34, 410-412.
55. Arakaki, N.; Nagao, T.; Niki, R.; Toyofuku, A.; Tanaka, H.; Kuramoto, Y.; Emoto, Y.; Shibata, H.; Magota, K.; Higuti, T. Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol. Cancer Res., 2003, 1, 931-939.
56. Berger, K.; Winzell, M.S.; Mei, J.; Erlanson-Albertsson, C. Enterostatin and its target mechanisms during regulation of fat intake. Physiol. Behav., 2004, 83, 623-630.
57. Champagne, E.; Martinez, L.O.; Collet, X.; Barbaras, R. Ecto-F1Fo ATP synthase/F1 ATPase: metabolic and immunological functions. Curr. Opin. Lipidol., 2006, 17, 279-284.
58. Kenan, D.J.; Wahl, M.L. Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention? J. Bioenerg. Biomembr., 2005, 37, 461-465.
59. Moser, T.L.; Kenan, D.J.; Ashley, T.A.; Roy, J.A.; Goodman, M.D.; Misra, U.K.; Cheek, D.J.; Pizzo, S.V. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad. Sci. USA, 2001, 98, 6656-6661.
60. Moser, T.L.; Stack, M.S.; Asplin, I.; Enghild, J.J.; Hojrup, P.; Everitt, L.; Hubchak, S.; Schnaper, H.W.; Pizzo, S.V. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA, 1999, 96, 2811-2816.
61. Percival, R.S.; Devine, D.A.; Duggal, M.S.; Chartron, S.; Marsh, P.D. The effect of cocoa polyphenols on the growth, metabolism, and biofilm formation by Streptococcus mutans and Streptococcus sanguinis. Eur. J. Oral Sci., 2006, 114, 343-348.
62. Duarte, S.; Gregoire, S.; Singh, A.P.; Vorsa, N.; Schaich, K.; Bowen, W.H.; Koo, H. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol. Lett., 2006, 257, 50-56.
63. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.; Neefs, J.M.; Winkler, H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarlier, V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science, 2005, 307, 223-227.
64. Cole, S.T.; Alzari, P.M. Microbiology: Enhanced: TB-A New Target, a New Drug. Science, 2005, 307, 214-215.
65. Weber, J.; Senior, A.E. Effects of the inhibitors azide, dicyclohexylcarbodiimide, and aurovertin on nucleotide binding to the three F1-ATPase catalytic sites measured using specific tryptophan probes. J. Biol. Chem., 1998, 273, 33210-33215.
66. Zheng, J.; Ramirez, V.D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol., 2000, 130, 1115-1123.
67. Frasch, A.C.; Cazzulo, J.J.; Stoppani, A.O. Solubilization and some properties of the Mg2+-activated adenosine triphosphatase from Trypanosoma cruzi. Comp. Biochem. Physiol. B., 1978, 61, 207-212.
68. Bowler, M.W.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. How azide inhibits ATP hydrolysis by the F-ATPases. Proc. Natl. Acad. Sci. USA, 2006, 103, 8646-8649.
69. Zharova, T.V.; Vinogradov, A.D. Energy-dependent transformation of F0.F1-ATPase in Paracoccus denitrificans plasma membranes. J. Biol. Chem., 2004, 279, 12319-12324.
70. Yoshida, M.; Allison, W.S.; Esch, F.S.; Futai, M. The specificity of carboxyl group modification during the inactivation of the Escherichia coli F1-ATPase with dicyclohexyl[14C]carbodiimide. J. Biol. Chem., 1982, 257, 10033-10037.
71. Hermolin, J.; Fillingame, R.H. H+-ATPase activity of Escherichia coli F1F0 is blocked after reaction of dicyclohexylcarbodiimide with a single proteolipid (subunit c) of the F0 complex. J. Biol. Chem., 1989, 264, 3896-3903.
72. Tommasino, M.; Capaldi, R.A. Effect of dicyclohexylcarbodiimide on unisite and multisite catalytic activities of the adenosinetriphosphatase of Escherichia coli. Biochemistry, 1985, 24, 3972-3976.
73. Abrahams, J.P.; Buchanan, S.K.; Van Raaij, M.J.; Fearnley, I.M.; Leslie, A.G.; Walker, J.E. The structure of bovine F1-ATPase complexed with the peptide antibiotic efrapeptin. Proc. Natl. Acad. Sci. USA, 1996, 93, 9420-9424.
74. Lardy, H.; Reed, P.; Lin, C.H. Antibiotic inhibitors of mitochondrial ATP synthesis. Fed. Proc., 1975, 34, 1707-1710.
75. Yarlett, N.; Lloyd, D. Effects of inhibitors on mitochondrial adenosine triphosphatase of Crithidia fasciculata: an unusual pattern of specificities. Mol. Biochem. Parasitol., 1981, 3, 13-17.
76. van Raaij, M.J.; Abrahams, J.P.; Leslie, A.G.; Walker, J.E. The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B. Proc. Natl. Acad. Sci. USA, 1996, 93, 6913-6917.
77. Gledhill, J.R.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 15671-15676.
78. Wise, J.G.; Duncan, T.M.; Latchney, L.R.; Cox, D.N.; Senior, A.E. Properties of F1-ATPase from the uncD412 mutant of Escherichia coli. Biochem. J., 1983, 215, 343-350.
79. Satre, M.; Bof, M.; Vignais, P.V. Interaction of Escherichia coli adenosine triphosphatase with aurovertin and citreoviridin: inhibition and fluorescence studies. J. Bacteriol., 1980, 142, 768-776.
80. Linnett, P.E.; Beechey, R.B. Inhibitors of the ATP synthethase system. Methods Enzymol., 1979, 55, 472-518.
81. Robinson, J.A. Polyketide synthase complexes: their structure and function in antibiotic biosynthesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 1991, 332, 107-114.
82. Wolvetang, E.J.; Johnson, K.L.; Krauer, K.; Ralph, S.J.; Linnane, A.W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett., 1994, 339, 40-44.
83. Mills, K.I.; Woodgate, L.J.; Gilkes, A.F.; Walsh, V.; Sweeney, M.C.; Brown, G.; Burnett, A.K. Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14. Biochem. Biophys. Res. Commun., 1999, 263, 294-300.
84. Gledhill, J.R.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc. Natl. Acad. Sci. USA, 2007, 104, 13632-13637.
85. Chinnam, N.; Dadi, P.K.; Sabri, S.A.; Ahmad, M.; Kabir, M.A.; Ahmad, Z. Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner. Int. J. Biol. Macromol., 2010, 46, 478-486.
86. Barta, I.; Smerak, P.; Polivkova, Z.; Sestakova, H.; Langova, M.; Turek, B.; Bartova, J. Current trends and perspectives in nutrition and cancer prevention. Neoplasma, 2006, 53, 19-25.
87. Nishino, H.; Murakoshi, M.; Mou, X.Y.; Wada, S.; Masuda, M.; Ohsaka, Y.; Satomi, Y.; Jinno, K. Cancer Prevention by Phytochemicals. Oncology, 2005, 69, 38-40.
88. Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.W.; Fong, H.H.S.; Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. Science, 1997, 275, 218-220.
89. Stahl, W.; Sies, H. Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol. Biotechnol., 2007, 37, 26-30.
90. Pervaiz, S. Resveratrol: from grapevines to mammalian biology. FASEB J., 2003, 17, 1975-1985.
91. Athar, M.; Back, J.H.; Kopelovich, L.; Bickers, D.R.; Kim, A.L. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch. Biochem. Biophys., 2009, 486, 95-102.
92. Athar, M.; Back, J.H.; Tang, X.; Kim, K.H.; Kopelovich, L.; Bickers, D.R.; Kim, A.L. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 2007, 224, 274-283.
93. Aziz, M.H.; Nihal, M.; Fu, V.X.; Jarrard, D.F.; Ahmad, N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther., 2006, 5, 1335-1341.
94. Wallace, D.C. Mitochondrial diseases in man and mouse. Science, 1999, 283, 1482-1488.
95. Wallace, D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet., 2005, 39, 359-407.
96. McMahon, G.A.; Petitclerc, E.; Stefansson, S.; Smith, E.; Wong, M.K.; Westrick, R.J.; Ginsburg, D.; Brooks, P.C.; Lawrence, D.A. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem., 2001, 276, 33964-33968.
97. Leik, C.E.; Su, E.J.; Nambi, P.; Crandall, D.L.; Lawrence, D.A. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J. Thromb. Haemost., 2006, 4, 2710-2715.
98. Lahouel, M.; Amedah, S.; Zellagui, A.; Touil, A.; Rhouati, S.; Benyache, F.; Leghouchi, E.; Bousseboua, H. The interaction of new plant flavonoids with rat liver mitochondria: relation between the anti- and pro-oxydant effect and flavonoids concentration. Therapie, 2006, 61, 347-355.
99. Glazebrook, J.; Ausubel, F.M. Isolation of phytoalexin-deficient mutants of Arabidopsis thaliana and characterization of their interactions with bacterial pathogens. Proc. Natl. Acad. Sci. USA, 1994, 91, 8955-8959.
100. Pirola, L.; Frojdo, S. Resveratrol: one molecule, many targets. IUBMB Life, 2008, 60, 323-332.
101. Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y.; Lamming, D.W.; Lavu, S.; Wood, J.G.; Zipkin, R.E.; Chung, P.; Kisielewski, A.; Zhang, L.L.; Scherer, B.; Sinclair, D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425, 191-196.
102. Wood, J.G.; Rogina, B.; Lavu, S.; Howitz, K.; Helfand, S.L.; Tatar, M.; Sinclair, D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 2004, 430, 686-689.
103. Valenzano, D.R.; Terzibasi, E.; Genade, T.; Cattaneo, A.; Domenici, L.; Cellerino, A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol., 2006, 16, 296-300.
104. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P.J.; Poosala, S.; Becker, K.G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K.W.; Spencer, R.G.; Lakatta, E.G.; Le Couteur, D.; Shaw, R.J.; Navas, P.; Puigserver, P.; Ingram, D.K.; de Cabo, R.; Sinclair, D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444, 337-342.
105. Clement, M.V.; Hirpara, J.L.; Chawdhury, S.H.; Pervaiz, S. Chemopreventive agent resveratrol, a natural product derived fromgrapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998, 92, 996-1002.
106. Spiller, G.A. Caffeine. CRC Press: Boca Raton, Fla. 1998.
107. [107] Hammerstone, J.F.; Lazarus, S.A.; Schmitz, H.H. Procyanidin content and variation in some commonly consumed foods. J. Nutr., 2000, 130, 2086S-2092S.
108. Ruidavets, J.; Teissedre, P.; Ferrieres, J.; Carando, S.; Bougard, G.; Cabanis, J. Catechin in the Mediterranean diet: vegetable, fruit or wine? Atherosclerosis, 2000, 153, 107-117.
109. Harborne, J.B.; Mabry, T.J.; Mabry, H. The Flavonoids. Chapman & Hall: London, 1975.
110. Chyu, K.Y.; Babbidge, S.M.; Zhao, X.; Dandillaya, R.; Rietveld, A.G.; Yano, J.; Dimayuga, P.; Cercek, B.; Shah, P.K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation, 2004, 109, 2448-2453.
111. Mittal, A.; Pate, M.S.; Wylie, R.C.; Tollefsbol, T.O.; Katiyar, S.K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol., 2004, 24, 703-710.
112. Li, C.; Allen, A.; Kwagh, J.; Doliba, N.M.; Qin, W.; Najafi, H.; Collins, H.W.; Matschinsky, F.M.; Stanley, C.A.; Smith, T.J. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J. Biol. Chem., 2006, 281, 10214-10221.
113. Puig, T.; Turrado, C.; Benhamu, B.; Aguilar, H.; Relat, J.; Ortega-Gutierrez, S.; Casals, G.; Marrero, P.F.; Urruticoechea, A.; Haro, D.; Lopez-Rodriguez, M.L.; Colomer, R. Novel inhibitors of fatty acid synthase with anticancer activity. Clin. Cancer Res., 2009, 15, 7608-7615.
114. Murase, T.; Haramizu, S.; Ota, N.; Hase, T. Tea catechin ingestion combined with habitual exercise suppresses the aging-associated decline in physical performance in senescence-accelerated mice. Am. J. Physiol. Regu. Integr. Comp. Physiol., 2008, 295, R281-289.
115. Kumar, N.; Kant, R.; Maurya, P.K. Concentration-dependent effect of (-) epicatechin in hypertensive patients. Phytother. Res., 2010.
116. Wu, D.; Kong, Y.; Han, C.; Chen, J.; Hu, L.; Jiang, H.; Shen, X. DAlanine: D-alanine ligase as a new target for the flavonoids quercetin and apigenin. Int. J. Antimicrob. Agents, 2008, 32, 421-426.
117. Walker, E.H.; Pacold, M.E.; Perisic, O.; Stephens, L.; Hawkins, P.T.; Wymann, M.P.; Williams, R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell, 2000, 6, 909-919.
118. Sicheri, F.; Moarefi, I.; Kuriyan, J. Crystal structure of the Src family tyrosine kinase Hck. Nature, 1997, 385, 602-609.
119. Zheng, J.; Ramirez, V.D. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem. Biophys. Res. Commun., 1999, 261, 499-503.
120. Gledhill, J.R.; Walker, J.E. Inhibition sites in F1-ATPase from bovine heart mitochondria. Biochem. J., 2005, 386, 591-598.
121. Bullough, D.A.; Ceccarelli, E.A.; Roise, D.; Allison, W.S.Inhibition of the bovine-heart mitochondrial F1-ATPase by cationic dyes and amphipathic peptides. Biochim. Biophys. Acta, 1989, 975, 377-383.
122. Kato-Yamada, Y.; Bald, D.; Koike, M.; Motohashi, K.; Hisabori, T.; Yoshida, M. Epsilon subunit, an endogenous inhibitor of bacterial F(1)-ATPase, also inhibits F(0)F(1)-ATPase. J. Biol. Chem., 1999, 274, 33991-33994.
123. Hara, K.Y.; Kato-Yamada, Y.; Kikuchi, Y.; Hisabori, T.; Yoshida, M. The role of the betaDELSEED motif of F1-ATPase: propagation of the inhibitory effect of the epsilon subunit. J. Biol. Chem., 2001, 276, 23969-23973.
124. Suzuki, T.; Murakami, T.; Iino, R.; Suzuki, J.; Ono, S.; Shirakihara, Y.; Yoshida, M. F0F1-ATPase/synthase is geared to the synthesis mode by conformational rearrangement of epsilon subunit in response to proton motive force and ADP/ATP balance. J. Biol. Chem., 2003, 278, 46840-46846.
125. Tsunoda, S.P.; Rodgers, A.J.; Aggeler, R.; Wilce, M.C.; Yoshida, M.; Capaldi, R.A. Large conformational changes of the epsilon subunit in the bacterial F1F0 ATP synthase provide a ratchet action to regulate this rotary motor enzyme. Proc. Natl. Acad. Sci. USA, 2001, 98, 6560-6564.
126. Lebowitz, M.S.; Pedersen, P.L. Regulation of the mitochondrial ATP synthase/ATPase complex: cDNA cloning, sequence, overexpression, and secondary structural characterization of a functional protein inhibitor. Arch. Biochem. Biophys., 1993, 301, 64-70.
127. Lebowitz, M.S.; Pedersen, P.L. Protein inhibitor of mitochondrial ATP synthase: relationship of inhibitor structure to pH-dependent regulation. Arch. Biochem. Biophys., 1996, 330, 342-354.
128. Van Heeke, G.; Deforce, L.; Schnizer, R.A.; Shaw, R.; Couton, J.M.; Shaw, G.; Song, P.S.; Schuster, S.M. Recombinant bovine heart mitochondrial F1-ATPase inhibitor protein: overproduction in Escherichia coli, purification, and structural studies. Biochemistry, 1993, 32, 10140-10149.
129. Cabezon, E.; Montgomery, M.G.; Leslie, A.G.; Walker, J.E. The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat. Struct. Biol., 2003, 10, 744-750.
130. Iwadate, M.; Asakura, T.; Williamson, M.P. The structure of the melittin tetramer at different temperatures-an NOE-based calculation with chemical shift refinement. Eur. J. Biochem., 1998, 257, 479-487.
131. Roise, D.; Horvath, S.J.; Tomich, J.M.; Richards, J.H.; Schatz, G. A chemically synthesized pre-sequence of an imported mitochondrial protein can form an amphiphilic helix and perturb natural and artificial phospholipid bilayers. EMBO J., 1986, 5, 1327-1334.
132. Terwilliger, T.C.; Eisenberg, D. The structure of melittin. I. Structure determination and partial refinement. J. Biol. Chem., 1982, 257, 6010-6015.
133. Roise, D.; Theiler, F.; Horvath, S.J.; Tomich, J.M.; Richards, J.H.; Allison, D.S.; Schatz, G. Amphiphilicity is essential for mitochondrial presequence function. EMBO J., 1988, 7, 649-653.
134. Powers, J.P.; Hancock, R.E. The relationship between peptide structure and antibacterial activity. Peptides, 2003, 24, 1681-1691.
135. Jakubke, H.-D.; Sewald, N. Peptides from A to Z: a concise encyclopedia. Wiley-VCH: Weinheim, 2008.
136. Boman, H.G.; Nilsson, I.; Rasmuson, B. Inducible antibacterial defence system in Drosophila. Nature, 1972, 237, 232-235.
137. Hultmark, D.; Steiner, H.; Rasmuson, T.; Boman, H.G. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem., 1980, 106, 7-16.
138. Steiner, H.; Hultmark, D.; Engstrom, A.; Bennich, H.; Boman, H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature, 1981, 292, 246-248.
139. Hoskin, D.W.; Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta, 2008, 1778, 357-375.
140. Mangoni, M.L.; Shai, Y. Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification. Biochim. Biophys. Acta, 2009, 1788, 1610-1619.
141. Martin, G.S.; Mannino, D.M.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med., 2003, 348, 1546-1554.
142. Rosenfeld, Y.; Papo, N.; Shai, Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem., 2006, 281, 1636-1643.
143. Wang, Z.; Wang, G. APD: the Antimicrobial Peptide Database. Nucleic Acids Res., 2004, 32, D590-592.
144. Zasloff, M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA, 1987, 84, 5449-5453.
145. Amiche, M.; Ladram, A.; Nicolas, P. A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae. Peptides, 2008, 29, 2074-2082.
146. Mangoni, M.L. Temporins, anti-infective peptides with expanding properties. Cell. Mol. Life Sci., 2006, 63, 1060-1069.
147. Oren, Z.; Shai, Y. Mode of action of linear amphipathic alphahelical antimicrobial peptides. Biopolymers, 1998, 47, 451-463.
148. Ludtke, S.J.; He, K.; Heller, W.T.; Harroun, T.A.; Yang, L.; Huang, H.W. Membrane pores induced by magainin. Biochemistry, 1996, 35, 13723-13728.
149. Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry, 1996, 35, 11361-11368.
150. Matsuzaki, K.; Nakamura, A.; Murase, O.; Sugishita, K.; Fujii, N.; Miyajima, K. Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry, 1997, 36, 2104-2111.
151. Shai, Y. Mode of action of membrane active antimicrobial peptides. Biopolymers, 2002, 66, 236-248.
152. Erspamer, V. Half a century of comparative research on biogenic amines and active peptides in amphibian skin and molluscan tissues. Comp. Biochem. Physiol. C., 1984, 79, 1-7.
153. Erspamer, V.; Falconieri Erspamer, G.; Cei, J.M. Active peptides in the skins of two hundred and thirty American amphibian species. Comp. Biochem. Physiol. C., 1986, 85, 125-137.
154. Davidson, C.; Benard, M.F.; Shaffer, H.B.; Parker, J.M.; O'Leary, C.; Conlon, J.M.; Rollins-Smith, L.A. Effects of chytrid and carbaryl exposure on survival, growth and skin peptide defenses in foothill yellow-legged frogs. Environ. Sci. Technol., 2007, 41, 1771-1776.
155. Rinaldi, A.C. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr. Opin. Chem. Biol., 2002, 6, 799-804.
156. Conlon, J.M.; Kolodziejek, J.; Nowotny, N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta, 2004, 1696, 1-14.
157. Conlon, J.M.; Al-Ghaferi, N.; Abraham, B.; Leprince, J. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods, 2007, 42, 349-357.
158. Papo, N.; Shai, Y. Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci., 2005, 62, 784-790.
159. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-395.
160. Mor, A.; Hani, K.; Nicolas, P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem., 1994, 269, 31635-31641.
161. Sayle, R.A.; Milner-White, E.J. RASMOL: biomolecular graphics for all. Trends Biochem. Sci., 1995, 20, 374.
162. Gesell, J.; Zasloff, M.; Opella, S.J. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J. Biomol. NMR, 1997, 9, 127-135.
163. Shalev, D.E.; Rotem, S.; Fish, A.; Mor, A. Consequences of Nacylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). J. Biol. Chem., 2006, 281, 9432-9438.
164. Conlon, J.M.; Sonnevend, A.; Davidson, C.; Smith, D.D.; Nielsen, P.F. The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem. Biophys. Res. Commun., 2004, 320, 170-175.
165. Rozek, T.; Wegener, K.L.; Bowie, J.H.; Olver, I.N.; Carver, J.A.; Wallace, J.C.; Tyler, M.J. The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem., 2000, 267, 5330-5341.
166. Mignogna, G.; Simmaco, M.; Kreil, G.; Barra, D. Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata. EMBO J., 1993, 12, 4829-4832.
167. Gibson, B.W.; Tang, D.Z.; Mandrell, R.; Kelly, M.; Spindel, E.R. Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J. Biol. Chem., 1991, 266, 23103-23111.
168. Yi, G.S.; Park, C.B.; Kim, S.C.; Cheong, C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett., 1996, 398, 87-90.
169. Wong, H.; Bowie, J.H.; Carver, J.A. The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida. Eur. J. Biochem., 1997, 247, 545-557.
170. Apponyi, M.A.; Pukala, T.L.; Brinkworth, C.S.; Maselli, V.M.; Bowie, J.H.; Tyler, M.J.; Booker, G.W.; Wallace, J.C.; Carver, J.A.; Separovic, F.; Doyle, J.; Llewellyn, L.E. Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance. Peptides, 2004, 25, 1035-1054.
171. Steinborner, S.T.; Currie, G.J.; Bowie, J.H.; Wallace, J.C.; Tyler, M.J. New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria. J. Pept. Res., 1998, 51, 121-126.
172. Wegener, K.L.; Wabnitz, P.A.; Carver, J.A.; Bowie, J.H.; Chia, B.C.; Wallace, J.C.; Tyler, M.J. Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1. Eur. J. Biochem., 1999, 265, 627-637.
173. Jin, L.L.; Song, S.S.; Li, Q.; Chen, Y.H.; Wang, Q.Y.; Hou, S.T. Identification and characterisation of a novel antimicrobial polypeptide from the skin secretion of a Chinese frog (Rana chensinensis). Int. J. Antimicrob. Agents, 2009, 33, 538-542.
174. Charpentier, S.; Amiche, M.; Mester, J.; Vouille, V.; Le Caer, J.P.; Nicolas, P.; Delfour, A. Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics. J. Biol. Chem., 1998, 273, 14690-14697.
175. Mor, A.; Nicolas, P. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem., 1994, 219, 145-154.
176. Lequin, O.; Ladram, A.; Chabbert, L.; Bruston, F.; Convert, O.; Vanhoye, D.; Chassaing, G.; Nicolas, P.; Amiche, M. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini. Biochemistry, 2006, 45, 468-480.
177. Batista, C.V.; Scaloni, A.; Rigden, D.J.; Silva, L.R.; Rodrigues Romero, A.; Dukor, R.; Sebben, A.; Talamo, F.; Bloch, C. A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta. FEBS Lett., 2001, 494, 85-89.
178. Jackway, R.J.; Bowie, J.H.; Bilusich, D.; Musgrave, I.F.; Surinya-Johnson, K.H.; Tyler, M.J.; Eichinger, P.C. The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins. Rapid Commun. Mass Spectrom., 2008, 22, 3207-3216.
179. Raftery, M.J.; Waugh, R.J.; Bowie, J.H.; Wallace, J.C.; Tyler, M.J. The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata. J. Pept. Sci., 1996, 2, 117-124.
180. Prates, M.V.; Sforca, M.L.; Regis, W.C.; Leite, J.R.; Silva, L.P.; Pertinhez, T.A.; Araujo, A.L.; Azevedo, R.B.; Spisni, A.; Bloch, C. Jr. The NMR-derived solution structure of a new cationic antimicrobial peptide from the skin secetion of the anuran Hyla punctata. J. Biol. Chem., 2004, 279, 13018-13026.
181. Castro, M.S.; Ferreira, T.C.; Cilli, E.M.; Crusca, E. Jr.; Mendes-Giannini, M.J.; Sebben, A.; Ricart, C.A.; Sousa, M.V.; Fontes, W. Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (spotted treefrog). Peptides, 2009, 30, 291-296.
182. Mattute, B.; Knoop, F.C.; Conlon, J.M. Kassinatuerin-1: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the hyperoliid frog, Kassina senegalensis. Biochem. Biophys. Res. Commun., 2000, 268, 433-436.
183. Rozek, T.; Waugh, R.J.; Steinborner, S.T.; Bowie, J.H.; Tyler, M.J.; Wallace, J.C. The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1. J. Pept. Sci., 1998, 4, 111-115.
184. Conlon, J.M.; Sonnevend, A.; Patel, M.; Camasamudram, V.; Nowotny, N.; Zilahi, E.; Iwamuro, S.; Nielsen, P.F.; Pal, T. A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties. Biochem. Biophys. Res. Commun., 2003, 306, 496-500.
185. Park, S.; Park, S.H.; Ahn, H.C.; Kim, S.; Kim, S.S.; Lee, B.J. Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. FEBS Lett., 2001, 507, 95-100.
186. Rollins-Smith, L.A.; King, J.D.; Nielsen, P.F.; Sonnevend, A.; Conlon, J.M. An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura: Leptodactylidae). Regul. Pept., 2005, 124, 173-178.
187. Li, J.; Xu, X.; Xu, C.; Zhou, W.; Zhang, K.; Yu, H.; Zhang, Y.; Zheng, Y.; Rees, H.H.; Lai, R.; Yang, D.; Wu, J. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteom., 2007, 6, 882-894.
188. Andreu, D.; Aschauer, H.; Kreil, G.; Merrifield, R.B. Solid-phase synthesis of PYLa and isolation of its natural counterpart, PGLa [PYLa-(4-24)] from skin secretion of Xenopus laevis. Eur. J. Biochem., 1985, 149, 531-535.
189. Leite, J.R.; Silva, L.P.; Rodrigues, M.I.; Prates, M.V.; Brand, G.D.; Lacava, B.M.; Azevedo, R.B.; Bocca, A.L.; Albuquerque, S.; Bloch, C. Jr. Phylloseptins: a novel class of anti-bacterial and antiprotozoan peptides from the Phyllomedusa genus. Peptides, 2005, 26, 565-573.
190. Pierre, T.N.; Seon, A.A.; Amiche, M.; Nicolas, P. Phylloxin, a novel peptide antibiotic of the dermaseptin family of antimicrobial/opioid peptide precursors. Eur. J. Biochem., 2000, 267, 370-378.
191. Olson, L. 3rd; Soto, A.M.; Knoop, F.C.; Conlon, J.M. Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog. Biochem. Biophys. Res. Commun., 2001, 288, 1001-1005.
192. Clark, D.P.; Durell, S.; Maloy, W.L.; Zasloff, M. Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J. Biol. Chem., 1994, 269, 10849-10855.
193. Simmaco, M.; Mignogna, G.; Canofeni, S.; Miele, R.; Mangoni, M.L.; Barra, D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem., 1996, 242, 788-792.
194. Abbassi, F.; Oury, B.; Blasco, T.; Sereno, D.; Bolbach, G.; Nicolas, P.; Hani, K.; Amiche, M.; Ladram, A. Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica. Peptides, 2008, 29, 1526-1533.
195. Chia, B.C.; Carver, J.A.; Mulhern, T.D.; Bowie, J.H. The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii. J. Pept. Res., 1999, 54, 137-145.
196. Ali, M.F.; Soto, A.; Knoop, F.C.; Conlon, J.M. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim. Biophys. Acta, 2001, 1550, 81-89.